Member Info for mazik

bidnolid..hah! hah! best post of the day:-)

Hugh dont take any notice of the garbage...until news "follow the money".

Hugh some have more time to waste hence the garbage post before midnight, coming back to N4P we expect an update this month.

Aim i am taking a rationale view and doing the research this week i have topped up to my 7 figure holding. So i am v

Proof of the pudding please :-)

The Company is currently awaiting confirmation that its first pre-clinical milestone has been achieved, which will result in the initial £500,000 payment from Newsummit Biopharma ("NSB"). In addition, the Company is on track to deliver its first human pharmacokinetic data in early 2019. MHRA clearance is expected in November 2018 with patients scheduled for dosing in January 2019. All clinical materials have been generated and are ready for study commencement at Quotient. Demonstration of bioequivalence to the reference product will trigger a further £2 million payment from NSB, whilst the marketing of the Rest of World rights will commence in Q3 2018

Lets see what we get from Nuformix, reply of my email and expecting funds RNS

Jiving I have written a mail to nuformix , lets see what answer I will get :-)

At least I can dare to look at my portfolio "its got get well soon" card over it...lol ! GLA I have had enough this morning I better go out and enjoy the sunny day get some Vitamin D in the process.

Pettycash will do..need to go to the bottom of this. Its all well to know the heavy weights in the advisory board and management team impressive board of directors. We as shareholders expect NFX to be more transparent on deal with Newsummit and need follow up news from the operational update of 2nd July... until then it looks like a Tea party of of the heavy weights without any substance. Lastly we need an update of the March RNS " Company is conducting a number of commercial discussions relating to its product pipeline".

Jiving very little news about them other than IPO F1 filed on Nasdaq in 2012, will contact NFX to get info about our deal with them.

Seems to be positive buying as its oversold, last year we were paying three times today's price..IMO.
Commerciial deals is what the market is expecting

Outlook from Dr Dan Gooding " licensing income of GBP2.5m due in 2019 and the formation of strategic collaborations, the foundations are in place for the next stage in our development and I believe that our strategy and business model will deliver significant growth in shareholder value."
This does gives a positive spin and hope for this year in my opinion its oversold IMO

Ok mate will have a look..

Apology bidnolid for my comment , its just I am having a off day.Good Luck to u.

Buyers realising this is a bargain, well spread have closed to show a fall ..IMO GLA

Do we need this miserable poster to put his own bad luck on us, if you were so good you would have done well with enet where you are at a loss..... You have just appeared from the woods, some of us have been here on this thread over a year and have substantial investment... " Follow the money" no advice intended....

Well looks like double figures this afternoon..GLA

Feel new broker for N4P is positive sign , as a shareholder feel the last broker has done no favours..lol!

Hope so, holding as sp does not reflect the reward